Morepen Laboratories 

₹117.40
76
+₹5.43+4.85% Thursday 10:00

統計

當日最高
118.55
當日最低
109.6
52週高點
118.55
52週低點
33.05
成交量
33,807,342
平均成交量
20,989,112
市值
64.33B
本益比
35.39
股息殖利率
0.17%
股息
0.2

即將到來

股息

0.17%股息殖利率
Sep 26
₹0.20
Aug 25
₹0.20
Sep 2
₹0.60
Sep 1
₹0.20
Jan 1
₹0.50
10年成長
不適用
5年成長
不適用
3年成長
不適用
1年成長
不適用

財報

3Aug預期
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
999
333
-333
-999
預期EPS
不適用
實際EPS
不適用

財務

5.54%利潤率
有盈利
2020
2021
2022
2023
2024
2025
26.43B營收
1.46B淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 MOREPENLAB.NSE 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Morepen Laboratories Limited is an Indian pharmaceutical company primarily engaged in the development, manufacturing, marketing, and distribution of active pharmaceutical ingredients (APIs), proprietary and generic pharmaceutical formulations, and a diverse range of home healthcare products. Its API portfolio encompasses compounds utilized in the creation of drugs for conditions such as allergies, asthma, elevated cholesterol, hypertension, and diabetes. The company also supplies an array of point-of-care and medical devices for home use, including diagnostic tools like air purifiers, thermometers, stethoscopes, blood pressure monitors, pulse oximeters, nebulizers, glucometers with accompanying strips, as well as hygiene products such as sanitizers, disinfectant solutions, masks, and gloves. Among its well-known branded products are Burnol, a cream for treating burns; Lemolate, an offering for cough and cold relief; and Fiber-X, a psyllium husk supplement. Furthermore, Morepen produces finished drug formulations covering various therapeutic areas, including gastrointestinal health, antibiotics, vitamins, nutritional support, anti-diabetics, and cardiovascular conditions. Beyond these offerings, the company undertakes contract manufacturing for other businesses and participates in brand sharing agreements. Its comprehensive range of over-the-counter (OTC) products is marketed under the recognizable Dr. Morepen brand. The company's global footprint extends to approximately 75 nations, where its products are exported. Established in 1984, Morepen Laboratories Limited maintains its headquarters in New Delhi, India.
Show more...
執行長
Sushil Suri
員工
2152
國家
印度
ISIN
INE083A01026

上市

0 Comments

分享你的想法

FAQ

Morepen Laboratories 今天的股價是多少?
MOREPENLAB.NSE 目前價格為 ₹117.40 INR,過去 24 小時上漲了 +4.85%。在圖表上更密切關注 Morepen Laboratories 股價表現。
Morepen Laboratories 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 NSE (India) 交易所,Morepen Laboratories 的股票以代號 MOREPENLAB.NSE 進行交易。
Morepen Laboratories 的股價在上漲嗎?
MOREPENLAB.NSE 股票較上週上漲 +10.56%,本月上漲 +69.7%,過去一年 Morepen Laboratories 上漲 +137.08%。
Morepen Laboratories 的市值是多少?
今天 Morepen Laboratories 的市值為 64.33B
Morepen Laboratories 去年的營收是多少?
Morepen Laboratories 去年的營收為 26.43BINR。
Morepen Laboratories 去年的淨利是多少?
MOREPENLAB.NSE 去年的淨收益為 1.46BINR。
Morepen Laboratories 會發放股息嗎?
是的,MOREPENLAB.NSE 的股息每 年度 發放一次。每股最新股息為 0.2 INR。截至今日,股息殖利率(FWD)% 為 0.17%。
Morepen Laboratories 有多少名員工?
截至 September 04, 2026,公司共有 2,152 名員工。
Morepen Laboratories 位於哪個產業?
Morepen Laboratories從事於Health & Wellness產業。
Morepen Laboratories 何時完成拆股?
Morepen Laboratories 最近沒有進行任何拆股。
Morepen Laboratories 的總部在哪裡?
Morepen Laboratories 的總部位於 印度 的 Gurugram。